Eastern Mediterranean (WHO region) vs El Salvador: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Eastern Mediterranean (WHO region)
61.0%
in 2025
El Salvador
98.0%
in 2025
Eastern Mediterranean (WHO region) rank
9th
El Salvador rank
11th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Eastern Mediterranean (WHO region)
- El Salvador
How they compare
El Salvador currently reports 98.0% against 61.0% in Eastern Mediterranean (WHO region), a difference of 37.0%.
That makes El Salvador's figure about 1.6 times Eastern Mediterranean (WHO region)'s.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was El Salvador ahead.
Eastern Mediterranean (WHO region) ranks 9th and El Salvador ranks 11th of 11 groups.
Across the 3 decades both report, Eastern Mediterranean (WHO region) averaged higher in 1 and El Salvador in 2.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 0.0% | 2.0% | Eastern Mediterranean (WHO region) |
| 2010s | 37.1% | 91.0% | 53.9% | El Salvador |
| 2020s | 54.7% | 94.7% | 40.0% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Eastern Mediterranean (WHO region) or El Salvador?
- El Salvador, at 98.0% against 61.0% in Eastern Mediterranean (WHO region) as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Eastern Mediterranean (WHO region) and El Salvador?
- 37.0%, with El Salvador ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and El Salvador?
- 18 years are reported by both, from 2008 to 2025.
- How do Eastern Mediterranean (WHO region) and El Salvador rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Eastern Mediterranean (WHO region) ranks 9th and El Salvador ranks 11th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.